oral semaglutide review Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Oral Semaglutide Pills: Benefits, Risks,

Improves facial balance and contours

For Continuing Therapy If you are already on Zepbound: A renewal PA is required at 29 weeks After that, PAs are required every 12 months You must generally demonstrate a 5% reduction in weight from your baseline Important Clarification for Members Switching from Another GLP-1 If you are continuing therapy on a GLP-1 weight loss medication other than Zepbound, such as Wegovy: even if your BMI is now below 30, if you have lost 5% or more of your baseline weight, you may still meet prior authorization criteria for Zepbound under continuation-of-therapy guidelines

If unsure, consult your healthcare provider about adjusting your schedule

It is not insulin